Analysts rate Uipath (PATH:NYE) Stock with a Strong Buy rating and $22 price target

Wells Fargo lowered the PATH stock price target to $16.

Based on the PATH Stock Forecast from 18 analysts, the average analyst PATH stock price target is USD 22.32 over the next 12 months. Uipath Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Uipath stock forecast is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Uipath stock price was USD 12.13Uipath stock price has changed by -0.08% over the past week, -1.90% over the past month and -75.74% over the last year.

 

About Uipath Inc. (PATH:NYE):

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. The company also provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

 

What we like:

High market capitalization:

PATH stock is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior risk adjusted returns:

PATH stock has performed well, on a risk adjusted basis, compared to its sector peers (for a hold period of at least 12 months) and is in the top quartile.

 

What we don’t like:

High volatility:

The total returns for PATH stock are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow:

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow:

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth:

PATH stock has shown below median earnings growth in the previous 5 years compared to its sector.